Shanghai Medicilon Inc. (SHA:688202)
China
· Delayed Price · Currency is CNY 69.50
+1.78 (2.63%)
Mar 9, 2026, 4:00 PM EDT
Shanghai Medicilon Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 9,142 | 4,033 | 9,209 | 18,612 | 30,145 | 9,748 | Upgrade
|
| Market Cap Growth | 111.42% | -56.21% | -50.52% | -38.26% | 209.24% | 169.46% | Upgrade
|
| Enterprise Value | 8,935 | 3,664 | 8,561 | 18,568 | 29,822 | 9,353 | Upgrade
|
| Last Close Price | 69.50 | 30.17 | 68.38 | 152.34 | 246.15 | 79.58 | Upgrade
|
| PE Ratio | - | - | - | 55.03 | 106.81 | 75.34 | Upgrade
|
| Forward PE | - | 51.44 | 51.44 | 51.44 | 51.44 | 51.44 | Upgrade
|
| PS Ratio | 8.47 | 3.89 | 6.74 | 11.22 | 25.83 | 14.64 | Upgrade
|
| PB Ratio | 4.43 | 1.88 | 3.67 | 11.61 | 22.71 | 8.58 | Upgrade
|
| P/TBV Ratio | 5.10 | 2.17 | 4.14 | 14.22 | 27.51 | 10.97 | Upgrade
|
| P/FCF Ratio | 452.82 | - | - | - | 188.15 | 109.47 | Upgrade
|
| P/OCF Ratio | 103.33 | - | 276.39 | - | 66.56 | 46.92 | Upgrade
|
| EV/Sales Ratio | 8.28 | 3.53 | 6.27 | 11.19 | 25.55 | 14.04 | Upgrade
|
| EV/EBITDA Ratio | - | - | 6304.74 | 48.34 | 84.13 | 57.18 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 57.56 | 96.68 | 69.29 | Upgrade
|
| EV/FCF Ratio | 442.52 | - | - | - | 186.13 | 105.03 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.16 | 0.15 | 0.17 | 0.03 | - | Upgrade
|
| Debt / EBITDA Ratio | - | - | 19.65 | 0.68 | 0.12 | - | Upgrade
|
| Debt / FCF Ratio | 18.14 | - | - | - | 0.27 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.17 | -0.24 | 0.05 | -0.35 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.14 | 1.26 | -447.19 | 0.20 | -1.32 | -2.85 | Upgrade
|
| Net Debt / FCF Ratio | -10.30 | 2.66 | 3.99 | -0.18 | -2.93 | -5.23 | Upgrade
|
| Asset Turnover | 0.38 | 0.34 | 0.49 | 0.81 | 0.74 | 0.53 | Upgrade
|
| Inventory Turnover | 8.86 | 7.47 | 6.30 | 7.73 | 11.01 | 17.67 | Upgrade
|
| Quick Ratio | 2.08 | 2.29 | 2.43 | 1.26 | 1.99 | 3.27 | Upgrade
|
| Current Ratio | 2.37 | 2.49 | 2.73 | 1.74 | 2.33 | 3.57 | Upgrade
|
| Return on Equity (ROE) | -10.50% | -14.23% | -1.62% | 23.09% | 23.11% | 12.56% | Upgrade
|
| Return on Assets (ROA) | -6.02% | -7.63% | -1.88% | 9.78% | 12.21% | 6.77% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.21% | -20.16% | -4.70% | 23.35% | 34.60% | 23.34% | Upgrade
|
| Return on Capital Employed (ROCE) | -12.40% | -16.50% | -3.30% | 18.80% | 21.90% | 11.60% | Upgrade
|
| Earnings Yield | -2.54% | -8.20% | -0.36% | 1.82% | 0.94% | 1.33% | Upgrade
|
| FCF Yield | 0.22% | -3.30% | -1.65% | -2.29% | 0.53% | 0.91% | Upgrade
|
| Dividend Yield | - | - | - | 0.18% | 0.28% | 0.40% | Upgrade
|
| Payout Ratio | - | - | - | 25.82% | 13.84% | - | Upgrade
|
| Buyback Yield / Dilution | 0.72% | -4.86% | -4.98% | -0.08% | -0.19% | -26.48% | Upgrade
|
| Total Shareholder Return | 0.72% | -4.86% | -4.98% | 0.11% | 0.09% | -26.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.